You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

HYDROXYCHLOROQUINE SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Hydroxychloroquine Sulfate patents expire, and when can generic versions of Hydroxychloroquine Sulfate launch?

Hydroxychloroquine Sulfate is a drug marketed by Accord Hlthcare, Alkaloida Zrt, Amneal Pharms Co, Appco, Aurobindo Pharma Usa, Chartwell Rx, Creekwood Pharms, Hikma Pharms, Ipca Labs Ltd, Laurus, Sandoz, Senores Pharms, Teva Pharms, Watson Labs, and Zydus Pharms Usa Inc. and is included in fifteen NDAs.

The generic ingredient in HYDROXYCHLOROQUINE SULFATE is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydroxychloroquine Sulfate

A generic version of HYDROXYCHLOROQUINE SULFATE was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROXYCHLOROQUINE SULFATE?
  • What are the global sales for HYDROXYCHLOROQUINE SULFATE?
  • What is Average Wholesale Price for HYDROXYCHLOROQUINE SULFATE?
Drug patent expirations by year for HYDROXYCHLOROQUINE SULFATE
Drug Sales Revenue Trends for HYDROXYCHLOROQUINE SULFATE

See drug sales revenues for HYDROXYCHLOROQUINE SULFATE

Recent Clinical Trials for HYDROXYCHLOROQUINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Henan Cancer HospitalPhase 2
West Virginia UniversityPhase 1/Phase 2
PfizerPhase 2

See all HYDROXYCHLOROQUINE SULFATE clinical trials

Pharmacology for HYDROXYCHLOROQUINE SULFATE
Medical Subject Heading (MeSH) Categories for HYDROXYCHLOROQUINE SULFATE

US Patents and Regulatory Information for HYDROXYCHLOROQUINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 213342-002 Aug 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Senores Pharms HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 212902-001 May 14, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Appco HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 210441-002 Sep 19, 2022 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.